Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate

por Liu, Ken, Chen, Jinbiao, Zhao, Yang, Boland, Jade, Ting, Ka Ka, Lockwood, Glen, McKenzie, Catriona, Kench, James, Vadas, Mathew A., Gamble, Jennifer R., McCaughan, Geoffrey W.
Publicado 2023

Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease

por Grzelak, Candice Alexandra, Sigglekow, Nicholas David, Tirnitz-Parker, Janina Elke Eleonore, Hamson, Elizabeth Jane, Warren, Alessandra, Maneck, Bharvi, Chen, Jinbiao, Patkunanathan, Bramilla, Boland, Jade, Cheng, Robert, Shackel, Nicholas Adam, Seth, Devanshi, Bowen, David Geoffrey, Martelotto, Luciano Gastón, Watkins, D. Neil, McCaughan, Geoffrey William
Publicado 2017

Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7

por Chen, Jinbiao, Zhao, Yang, Zhang, Fan, Li, Jia, Boland, Jade A., Cheng, Ngan Ching, Liu, Ken, Tiffen, Jessamy C., Bertolino, Patrick, Bowen, David G., Krueger, Andreas, Lisowski, Leszek, Alexander, Ian E., Vadas, Mathew A., El-Omar, Emad, Gamble, Jennifer R., McCaughan, Geoffrey W.
Publicado 2022